Results 141 to 150 of about 33,657 (222)

Intention to Receive the TAK-003 Dengue Vaccine and Associated Factors Among Adults in Rural Northern Thailand. [PDF]

Vaccines (Basel)
Polpitakchai C, Pangprasertkul S, Rusmevichientong P, Yamsiri R, Panumasvivat J, Sirikul W, Sapbamrer R, Luo S, Lin C, Kitro A.   +9 more
europepmc   +1 more source

The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine. [PDF]

NPJ Vaccines
Escudero I, Gniel D, Biswal S, Petri E, Perez G, Sharma M, Weil J, Wallace D.   +7 more
europepmc   +1 more source

Efficacy, public health impact and optimal use of the Takeda dengue vaccine. [PDF]

Nat Med
Cracknell Daniels B, Ferguson NM, Dorigatti I.   +2 more
europepmc   +2 more sources

The urgent need for a licensed dengue vaccine in the Philippines. [PDF]

Ther Adv Vaccines Immunother
Cordero DA.
europepmc   +1 more source

Willingness to pay for a dengue vaccine in Iran: Insights from a contingent valuation study. [PDF]

PLoS Negl Trop Dis
Soofi M, Kazemi-Karyani A, Alipoor Z, Mahmoodi H, Karamimatin B.   +4 more
europepmc   +1 more source

Dengue Serostatus and Dengue Vaccine Safety and Efficacy

New England Journal of Medicine, 2018
Klara M, Posfay-Barbe, Arnaud G, L’Huillier   +1 more
openaire   +4 more sources

Dengue vaccine effectiveness and safety: a systematic analysis of recent clinical trial data. [PDF]

Virol J
Kant R, Singh A, Ali AB, Nagre S, Ganguly NK, Rana R.   +5 more
europepmc   +1 more source

A dengue vaccine whirlwind update. [PDF]

Ther Adv Infect Dis, 2023
Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S, Boggild AK.   +4 more
europepmc   +1 more source

T-Cell-Based Universal Dengue Vaccine Design for Robust Protective Response. [PDF]

Vaccines (Basel)
Sun YF, Yeo Syin Lian A, Moi ML.
europepmc   +1 more source

Dengue vaccine rollout in India: lessons for Pakistan's public health preparedness. [PDF]

Ann Med Surg (Lond)
Sah S, Ahsan A, Tariq R, Yadav T.
europepmc   +1 more source